Berg, Gertrud

Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131

Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism

Ophthalmology and Eye DisordersThyroid Disorders and Treatments

Cited by 262

Incidence of hyperthyroidism in Sweden

Abraham-Nordling, M., Byström, K., Törring, O., Lantz, M., Berg, G., Calissendorff, J., Nyström, H. F., Jansson, S., Jörneskog, G., Karlsson, F. A., et al. (2011) · European Journal of Endocrinology

Thyroid Disorders and TreatmentsOphthalmology and Eye Disorders

Cited by 251

Cancer mortality after iodine‐131 therapy for hyperthyroidism

Hall, P., Berg, G., Bjelkengren, G., Boice, J. D., Ericsson, U., Hallquist, A., Lidberg, M., Lundell, G., Tennvall, J., Wiklund, K., et al. (1992) · International Journal of Cancer

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 124

Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine

Abraham-Nordling, M., Wallin, G., Träisk, F., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., Åsman, P., et al. (2010) · European Journal of Endocrinology

Ophthalmology and Eye DisordersThyroid Disorders and Treatments

Cited by 35